当前位置:首页 - 行情中心 - 科前生物(688526) - 财务分析

科前生物

(688526)

  

流通市值:75.47亿  总市值:75.47亿
流通股本:4.66亿   总股本:4.66亿

科前生物(688526)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.37亿元,每股收益0.72元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益417281.60万元,未分配利润229533.18万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产475302.75万元,负债58021.15万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入737,863,251.81487,290,650.57245,188,828.52941,923,862.86
营业总成本401,181,258.98257,541,676.39133,324,710.25547,793,468.42
其他经营收益
营业利润390,312,391.04253,742,611.24125,673,639.93438,847,655.41
利润总额388,971,331.63253,574,907.97125,495,051438,132,852.89
净利润336,604,771.84219,277,761.2107,786,272.75381,489,646.31
每股收益
其他综合收益47,672,522.1550,736,402.8315,356,455.6-42,473,821.86
综合收益总额384,277,293.99270,014,164.03123,142,728.35339,015,824.45
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,623,048,563.62,488,160,848.662,581,193,766.692,473,078,015.08
非流动资产:
非流动资产合计2,129,978,898.432,087,178,432.882,058,360,711.972,022,743,900.98
资产总计4,753,027,462.034,575,339,281.544,639,554,478.664,495,821,916.06
流动负债:
流动负债合计495,111,884.23435,314,172.13484,790,463.33463,498,149
非流动负债:
非流动负债合计85,099,575.7884,998,694.4189,673,839.5189,300,556.1
负债合计580,211,460.01520,312,866.54574,464,302.84552,798,705.1
所有者权益(或股东权益):
归属于母公司股东权益合计4,171,949,496.464,053,591,441.344,063,487,267.593,940,969,701
股东权益合计4,172,816,002.024,055,026,4154,065,090,175.823,943,023,210.96
负债和股东权益合计4,753,027,462.034,575,339,281.544,639,554,478.664,495,821,916.06
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计769,938,493.15488,335,269.01315,702,694.25880,495,177.8
经营活动现金流出小计454,224,365.56314,009,274.33175,664,858.92487,813,365.48
经营活动产生的现金流量净额315,714,127.59174,325,994.68140,037,835.33392,681,812.32
投资活动产生的现金流量:
投资活动现金流入小计1,786,395,731.32674,042,015.34184,593,447.791,376,379,491.94
投资活动现金流出小计2,185,017,604.22613,201,871.38267,069,313.831,279,792,231.11
投资活动产生的现金流量净额-398,621,872.960,840,143.96-82,475,866.0496,587,260.83
筹资活动产生的现金流量:
筹资活动现金流入小计17,692,58417,692,584-121,791,961.57
筹资活动现金流出小计201,250,823.46201,007,316.381,105,814.69624,968,953.77
筹资活动产生的现金流量净额-183,558,239.46-183,314,732.38-1,105,814.69-503,176,992.2
汇率变动对现金及现金等价物的影响-47,468.47-505,291.59-7,459.4917,728.85
现金及现金等价物净增加额-266,513,453.2451,346,114.6756,448,695.11-13,890,190.2
期末现金及现金等价物余额276,965,139.5594,824,707.41599,927,287.85543,478,592.74
补充资料:
现金及现金等价物的净增加额-51,346,114.67--13,890,190.2
最新报告期:2025-11-09
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
天风证券吴立,陈潇0.901.121.332025-11-09
西部证券熊航1.001.161.352025-11-01
开源证券王高展,陈雪丽1.031.261.512025-11-01
国海证券熊子兴,程一胜0.931.121.312025-11-01
太平洋李忠华,程晓东0.991.331.592025-10-31
TOP↑